Clinical Trial Update: Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration [Phase 4]

View source ↗

Summary

Phase 4 randomized crossover trial assessing tolerability of gonadotropin-releasing hormone analogue administration in prostate cancer; results have been posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• GnRH analogue (Gonadotropin-releasing hormone agonist)

Snippet

Sponsor: Watson Pharmaceuticals | Conditions: Prostate Cancer | Phase 4 | Status: COMPLETED | Results posted: 2013-09-06